Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Treasury Shares (2021 - 2025)

Silo Pharma's Treasury Shares history spans 5 years, with the latest figure at $7.2 million for Q3 2025.

  • For Q3 2025, Treasury Shares rose 188313.28% year-over-year to $7.2 million; the TTM value through Sep 2025 reached $7.2 million, up 188313.28%, while the annual FY2023 figure was $252855.0, 37.5% down from the prior year.
  • Treasury Shares for Q3 2024 was $6268.0 at Silo Pharma, down from $644234.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $17.4 million in Q1 2022 and bottomed at $3840.0 in Q3 2024.
  • The 5-year median for Treasury Shares is $355710.0 (2024), against an average of $3.8 million.
  • The largest YoY upside for Treasury Shares was 3876.51% in 2024 against a maximum downside of 96.13% in 2024.
  • A 2-year view of Treasury Shares shows it stood at $471121.0 in 2023, then plummeted by 98.67% to $6268.0 in 2024.
  • Per Business Quant, the three most recent readings for SILO's Treasury Shares are $7.2 million (Q3 2025), $8.3 million (Q2 2025), and $355710.0 (Q4 2024).